ArticleESMO open2024
Fruquintinib in refractory metastatic colorectal cancer: a multicenter real-world study.
D Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleESMO open2024
D Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.